Brief: IN8bio Presents Biologic Correlative Data from the INB-200 Phase 1 Trial in Newly Diagnosed Glioblastoma
06/11/2023 14:13
Nov 6 (Reuters) - IN8BIO, Inc. INAB.O :
* IN8BIO PRESENTS BIOLOGIC CORRELATIVE DATA FROM THE INB-200
PHASE
1 TRIAL IN NEWLY DIAGNOSED GLIOBLASTOMA AT THE SOCIETY FOR
IMMUNOTHERAPY OF CANCER (SITC) 38TH ANNUAL MEETING
Source text for Eikon: ID:nGNX8VGqgt
Further company coverage: INAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IN8bio
See all newsIN8bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm IN8bio's Q2 net loss narrows as expenses decline
IN8bio Inc expected to post a loss of 37 cents a share - Earnings Preview
Brief: IN8BIO - Enters Capital On Demand Sales Agreement With Jonestrading For ATM Offering
IN8bio Q1 net loss narrows as R&D expenses fall